<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Obstructive sleep apnea in pregnancy</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Obstructive sleep apnea in pregnancy</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Obstructive sleep apnea in pregnancy</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Judette Louis, MD, MPH</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Grace W Pien, MD, MS</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Vincenzo Berghella, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Nancy Collop, MD</a></dd><dt><span> </span>Deputy Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Alana Chakrabarti, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Geraldine Finlay, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Dec 19, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H13387151"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Obstructive sleep apnea (OSA) refers to apneas and hypopneas (absent or severely reduced airflow, respectively) that occur during sleep despite respiratory effort. Central sleep apnea (CSA) is defined by episodes of cessation of airflow due to absent breathing effort. Collectively, OSA and CSA are referred to as sleep-disordered breathing (SDB).</p><p>While the diagnosis and management of OSA are similar in pregnant and nonpregnant patients, some aspects are unique to pregnancy. This topic will focus on these unique details. Discussions regarding the diagnosis and management of OSA and CSA in nonpregnant patients are reviewed separately. (See  <a class="medical medical_review" href="/d/html/7706.html" rel="external">"Clinical presentation and diagnosis of obstructive sleep apnea in adults"</a> and  <a class="medical medical_review" href="/d/html/7695.html" rel="external">"Obstructive sleep apnea: Overview of management in adults"</a> and  <a class="medical medical_review" href="/d/html/7701.html" rel="external">"Central sleep apnea: Risk factors, clinical presentation, and diagnosis"</a> and  <a class="medical medical_review" href="/d/html/7675.html" rel="external">"Central sleep apnea: Treatment"</a>.)</p><p class="headingAnchor" id="H473216504"><span class="h1">PREVALENCE</span><span class="headingEndMark"> — </span>The prevalence of objectively determined OSA in pregnant patients is poorly studied. Rates range from 3 to 27 percent and vary depending on gestational age and method used to diagnose OSA [<a href="#rid1">1,2</a>]. Rates may be higher than those reported in the nonpregnant population of reproductive-age females, where the prevalence of OSA has been estimated to be 0.7 to 6.5 percent [<a href="#rid3">3-6</a>].</p><p class="bulletIndent1"><span class="glyph">●</span>In one prospective study of 105 pregnant patients who underwent polysomnography, the prevalence of OSA (defined as apnea-hypopnea index [AHI] ≥5 events/hour of sleep) was 10.5 percent in the first trimester and rose to 26.7 percent in the third trimester [<a href="#rid1">1</a>]. Among the 28 patients with OSA in the third trimester, the disorder was mild (AHI 5 to 14) in 23 patients, moderate (AHI 15 to 29) in 4 patients, and severe (AHI ≥30) in 1 patient.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In the largest cohort study to date that included over 3300 patients (with a substantive proportion of Black and Hispanic females) undergoing level 3 home sleep apnea testing, the prevalence of gestational OSA in early pregnancy (between 6 and 15 weeks of gestation) and mid-pregnancy (between 22 and 31 weeks of gestation) was 3.6 and 8.3 percent, respectively [<a href="#rid2">2</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In a prospective cohort study including 100 pregnant patients between 10 to 20 weeks gestation undergoing screening with home sleep apnea testing, patients with chronic hypertension had higher rates of OSA compared with controls matched for body mass index (BMI; 64 versus 38 percent, odds ratio [OR] 2.9, 95%CI 1.3–6.7) [<a href="#rid7">7</a>]. After controlling for age, prevalence of OSA was also higher in patients &gt;25 years with chronic hypertension (OR 2.6, 95% CI 1.1–6.7). </p><p></p><p class="headingAnchor" id="H473217103"><span class="h1">PATHOGENESIS</span><span class="headingEndMark"> — </span>In addition to pathogenetic factors that contribute to the development of OSA in nonpregnant patients (see  <a class="medical medical_review" href="/d/html/7712.html" rel="external">"Pathophysiology of upper airway obstruction in obstructive sleep apnea in adults"</a>), numerous hormonal and physiologic changes occur in pregnancy which may also contribute to the development and severity of OSA in pregnant patients, including the following:</p><p class="bulletIndent1"><span class="glyph">●</span>Narrow oropharynx – Oropharyngeal diameter appears to narrow and the Mallampati score increases as pregnancy progresses [<a href="#rid8">8,9</a>]. Although the role of airway narrowing in OSA has not been studied in pregnancy, there is a link between OSA and smaller internal size of the airway in the general population. (See  <a class="medical medical_review" href="/d/html/275.html" rel="external">"Approach to the difficult airway in adults for emergency medicine and critical care", section on 'M: Mallampati score'</a>.)</p><p></p><p class="bulletIndent1">In healthy nonpregnant individuals, studies have shown that fluid displacement from the legs into the neck reduces upper airway size and increases upper airway collapsibility [<a href="#rid10">10,11</a>]. Fluid shifts induced by prolonged sitting and recumbency have been strongly related to the degree of OSA [<a href="#rid12">12</a>], although other data have found that such rostral fluid shifts do not increase the frequency of obstructed breathing events [<a href="#rid13">13</a>]. Given that maternal blood volume increases, on average, 40 to 45 percent during pregnancy above nonpregnant levels [<a href="#rid14">14</a>], recumbency has the potential to adversely affect upper airway function and possibly contribute to OSA.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Reduced nasal patency – Nasal patency is reduced during pregnancy secondary to hyperemia and edema of the nasal mucosa [<a href="#rid15">15</a>]. Changes in the nasal mucosa may be due to increased blood flow and variations in circulating levels of estrogen and progesterone. Increased nasal congestion may lead to increased upper airway resistance and more negative intra-pharyngeal pressure with inspiration, in turn predisposing patients in late pregnancy to airway narrowing, and possibly snoring and obstructed breathing during sleep.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Hormonal changes – Increase in progesterone levels during pregnancy leads to increased tidal volume and results in increased minute ventilation [<a href="#rid16">16</a>], either due to direct effects on respiratory drive or enhanced sensitivity of the brain's respiratory center to carbon dioxide [<a href="#rid17">17</a>]. Increased ventilatory drive during pregnancy may enhance loop gain (the ratio of a corrective ventilatory response to a disturbance); if the response exceeds the disturbance (ie, loop gain &gt;1), then self-sustaining periodic breathing with central apneas may result. Alternatively, lower progesterone levels have been observed in pregnant patients with OSA compared with patients without OSA, suggesting that progesterone may play a protective role against OSA [<a href="#rid18">18</a>]. (See  <a class="medical medical_review" href="/d/html/14911.html" rel="external">"Treatment-emergent central sleep apnea", section on 'Pathogenesis'</a>.)</p><p></p><p class="headingAnchor" id="H2235350584"><span class="h1">CLINICAL MANIFESTATIONS</span><span class="headingEndMark"> — </span>The clinical manifestations of OSA are similar in pregnant and nonpregnant patients  (<a class="graphic graphic_table graphicRef55633" href="/d/graphic/55633.html" rel="external">table 1</a>) and are described in detail separately. (See  <a class="medical medical_review" href="/d/html/7706.html" rel="external">"Clinical presentation and diagnosis of obstructive sleep apnea in adults"</a>.) </p><p>However, some features overlap with those of normal pregnancy. For example, sleepiness is widely reported by pregnant patients, especially during the first trimester. Pregnancy-related causes of maternal awakening and arousal include fetal movement, urination urge, nocturnal dyspepsia, and leg cramps. All of these symptoms are common in late pregnancy and contribute to sleep fragmentation [<a href="#rid3">3,19</a>]. Thus, what is considered "normal" versus "abnormal" sleepiness in this population is not clear.</p><p class="headingAnchor" id="H473216532"><span class="h1">DIAGNOSTIC EVALUATION</span></p><p class="headingAnchor" id="H3613303696"><span class="h2">Differential diagnosis</span><span class="headingEndMark"> — </span>The differential diagnosis of OSA in pregnancy is similar to that in nonpregnant patients; many of these symptoms (eg, excessive daytime sleepiness, gastroesophageal reflux disease) are also common in normal pregnancy. The differential diagnosis of daytime sleepiness and OSA are provided separately. (See  <a class="medical medical_review" href="/d/html/7706.html" rel="external">"Clinical presentation and diagnosis of obstructive sleep apnea in adults", section on 'Differential diagnosis'</a> and  <a class="medical medical_review" href="/d/html/14892.html" rel="external">"Approach to the patient with excessive daytime sleepiness"</a>.) </p><p class="headingAnchor" id="H3363301947"><span class="h2">When to suspect OSA</span><span class="headingEndMark"> — </span>We maintain a high level of clinical suspicion for OSA in pregnant patients. When suspected, we refer the patient to a sleep specialist for evaluation. Data suggest that clinicians perform poorly when evaluating pregnant patients for OSA. In one cross-sectional survey, only 5 percent of patients were asked about snoring by their provider at a prenatal visit; of these patients, 32 percent reported snoring [<a href="#rid20">20</a>].</p><p>It is prudent during at least one prenatal visit that such patients be asked about the quality, quantity, and nature of their sleep. In our practice, the following factors raise the suspicion for OSA and prompt further evaluation by a sleep specialist [<a href="#rid1">1,21-24</a>]: </p><p class="bulletIndent1"><span class="glyph">●</span>Symptoms or signs suggestive of OSA  (<a class="graphic graphic_table graphicRef55633" href="/d/graphic/55633.html" rel="external">table 1</a>), particularly, habitual loud snoring, apneic symptoms (eg, choking or gasping that wake patients from sleep), apneas witnessed by a bed partner or roommate, symptoms of excessive daytime sleepiness (eg, drowsy driving), obesity, excessive gestational weight gain, narrow oropharynx, and large neck circumference  (<a class="graphic graphic_table graphicRef55633" href="/d/graphic/55633.html" rel="external">table 1</a> and <a class="graphic graphic_table graphicRef86812" href="/d/graphic/86812.html" rel="external">table 2</a>). (See  <a class="medical medical_review" href="/d/html/7706.html" rel="external">"Clinical presentation and diagnosis of obstructive sleep apnea in adults", section on 'Clinical features'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Frequent snoring (self-reported snoring ≥3 days per week). </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Risk factors for OSA (eg, older age [eg, &gt;35 years], increased body mass index [BMI], chronic hypertension, obesity-related comorbid conditions). These are discussed in detail separately. (See  <a class="medical medical_review" href="/d/html/7706.html" rel="external">"Clinical presentation and diagnosis of obstructive sleep apnea in adults", section on 'Risk factors and associated conditions'</a>.)</p><p></p><p class="bulletIndent1">Data that support these risk factors for OSA in pregnant patients are limited. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In one study of nulliparous pregnant patients, logistic regression modeling found that older age, higher BMI, and frequent snoring achieved good prediction of prevalent and incident sleep-disordered breathing (SDB; sensitivity 46 to 61 percent, specificity 90 percent) [<a href="#rid25">25</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Another model utilizing BMI, age, and presence of tongue enlargement (BATE) had a sensitivity of 76 to 79 percent with 82 percent specificity and was particularly accurate in Black patients [<a href="#rid26">26</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In a prospective study including 72 pregnant patients undergoing two level-3 sleep studies performed between 12 to 22 weeks and 32 to 38 weeks of gestation, those with class III obesity compared with those without obesity had higher rates of OSA (38 and 50 percent versus 3 and 9 percent, respectively) [<a href="#rid23">23</a>]. Age was also an independent risk factor.</p><p></p><p>In our practice, we do <strong>not</strong> use screening questionnaires (eg, STOP-Bang, Berlin) to evaluate pregnant patients for OSA. While screening questionnaires are inexpensive and easy to administer, they are poorly predictive in the nonpregnant population, and their weaknesses may be even more prominent in pregnant patients [<a href="#rid24">24,27-31</a>]. In a prospective study including 288 pregnant patients evaluated with six OSA screening tools (Berlin, American Society of Anesthesiologists checklist, STOP, STOP-BANG, Flemons Index, and Epworth Sleepiness Scale), the overall predictive ability of the screening tools for OSA was only modest [<a href="#rid28">28</a>]. (See  <a class="medical medical_review" href="/d/html/7706.html" rel="external">"Clinical presentation and diagnosis of obstructive sleep apnea in adults", section on 'Screening questionnaires'</a>.)</p><p class="headingAnchor" id="H473216554"><span class="h2">Objective testing (home or in-laboratory)</span><span class="headingEndMark"> — </span>For most pregnant patients in whom we suspect OSA, we prefer full-night, attended, in-laboratory polysomnography (PSG), which is the diagnostic gold standard for OSA. However, similar to nonpregnant patients, for patients in whom uncomplicated OSA is suspected (ie, absence of other conditions  (<a class="graphic graphic_table graphicRef121158" href="/d/graphic/121158.html" rel="external">table 3</a>) that can affect breathing during sleep) and in whom the pretest probability is estimated as moderate or severe, unattended home sleep apnea testing (HSAT) with a type 3 device is a reasonable alternative to in-laboratory PSG. (See  <a class="medical medical_review" href="/d/html/7694.html" rel="external">"Home sleep apnea testing for obstructive sleep apnea in adults", section on 'Type 3 devices (portable devices)'</a>.)</p><p>In our practice, we also typically use HSAT to evaluate pregnant patients for OSA when PSG is not initially approved due to insurance restrictions or declined by the patient. If home testing does not demonstrate OSA but clinical suspicion remains high or comorbidities exist that may result in SDB, we generally pursue PSG. Indications for HSAT and PSG in nonpregnant patients are provided in the table  (<a class="graphic graphic_table graphicRef119877" href="/d/graphic/119877.html" rel="external">table 4</a>) and details that inform this choice are also provided separately. (See  <a class="medical medical_review" href="/d/html/7706.html" rel="external">"Clinical presentation and diagnosis of obstructive sleep apnea in adults"</a> and  <a class="medical medical_review" href="/d/html/7706.html" rel="external">"Clinical presentation and diagnosis of obstructive sleep apnea in adults", section on 'Selecting home or in-laboratory testing'</a>.)</p><p>While guidelines from the American Academy of Sleep Medicine (AASM) recommend <strong>against</strong> the use of home sleep apnea testing for OSA diagnosis in patient groups with comorbidities, pregnancy is not specified as a contraindication [<a href="#rid32">32</a>]. Similarly, the AASM recommends that HSAT be used only in populations with substantive data on sensitivity and specificity [<a href="#rid33">33</a>]. Although substantive data on the value of HSAT in pregnancy are not available, limited data do suggest some value during pregnancy [<a href="#rid34">34,35</a>]. For example, in an observational study that demonstrated increased risk for adverse outcomes among patients with gestational OSA, HSAT was used to identify pregnant patients with OSA, suggesting that this methodology may be sufficiently sensitive to identify clinically significant cases of OSA in pregnant patients [<a href="#rid36">36</a>]. In a subsequent prospective study of 92 pregnant patients with suspected OSA, the apnea-hypopnea index (AHI) was similar when HSAT was compared with PSG (performed within the same week) [<a href="#rid37">37</a>]. Based on an AHI threshold of ≥5 events/hour, HSAT had a positive-predictive value of 85 percent and a negative-predictive value of 92 percent [<a href="#rid37">37</a>]. </p><p class="headingAnchor" id="H2270806898"><span class="h1">DIAGNOSIS AND CLASSIFICATION OF SEVERITY</span><span class="headingEndMark"> — </span>The diagnostic criteria for OSA in pregnant patients are similar to those in nonpregnant patients. Patients who meet criteria are traditionally classified as having mild, moderate, or severe disease on the basis of the apnea-hypopnea index (AHI) and symptoms. However, while we typically use these criteria and classification system, there are no studies describing normative data in pregnant patients. Further details on diagnostic criteria and classification are provided separately. (See  <a class="medical medical_review" href="/d/html/7706.html" rel="external">"Clinical presentation and diagnosis of obstructive sleep apnea in adults", section on 'Diagnosis'</a>.)</p><p class="headingAnchor" id="H4134960311"><span class="h1">ANTEPARTUM MANAGEMENT</span><span class="headingEndMark"> — </span>Our management strategy is based on our experience, indirect data from nonpregnant patients in whom efficacy is proven, and limited evidence that treatment during pregnancy impacts maternal or neonatal morbidity. In the absence of scientific evidence, clinicians have used their own protocols [<a href="#rid38">38</a>] or followed the published recommendations for treatment in the nonpregnant population [<a href="#rid39">39-42</a>].</p><p class="headingAnchor" id="H3899228744"><span class="h2">Management of OSA</span><span class="headingEndMark"> — </span>Patients who are pregnant and have OSA should be managed by a sleep medicine specialist. Most patients are managed in a similar fashion to those who are not pregnant. This includes patient education, behavior modification (eg, avoidance of sedatives and alcohol), and positive airway pressure (PAP), the latter of which is the mainstay of therapy for most patients with moderate to severe OSA. Behavior modification, indications for PAP (typically auto-adjusting PAP [APAP]), PAP titration modules, and target goals for PAP are discussed separately. (See  <a class="medical medical_review" href="/d/html/7695.html" rel="external">"Obstructive sleep apnea: Overview of management in adults", section on 'General issues for all patients'</a> and  <a class="medical medical_review" href="/d/html/7695.html" rel="external">"Obstructive sleep apnea: Overview of management in adults", section on 'Positive airway pressure (PAP) therapy'</a> and  <a class="medical medical_review" href="/d/html/99556.html" rel="external">"Mode selection for titration of positive airway pressure in adults with obstructive sleep apnea"</a> and  <a class="medical medical_review" href="/d/html/7677.html" rel="external">"Titration of positive airway pressure therapy for adults with obstructive sleep apnea"</a>.)</p><p>Pregnancy-specific management issues are discussed in the sections below. </p><p class="headingAnchor" id="H911434715"><span class="h3">Behavior modification</span><span class="headingEndMark"> — </span>Recommendations for behavior modifications are similar to nonpregnant patients (eg, avoidance of sedatives and alcohol). However, the exception is weight loss. Weight loss, which has been demonstrated to improve comorbid conditions and decrease the overall apnea-hypopnea index (AHI), is <strong>not </strong>typically recommended in pregnancy due to the potential for harm (eg, increased risk of having a small for gestational age of the newborn). However, we encourage patients to achieve gestational weight gain at the lower limit of the range recommended by the Institute of Medicine, which, may benefit an individual's risk for pregnancy related morbidity from worsening OSA control. (See  <a class="medical medical_review" href="/d/html/441.html" rel="external">"Gestational weight gain", section on 'Recommendations for gestational weight gain'</a>.) </p><p>The impact of incidental weight loss (eg, from hyperemesis gravidarum) on OSA control has not been studied. </p><p class="headingAnchor" id="H2010485434"><span class="h3">Positive airway pressure</span><span class="headingEndMark"> — </span>PAP therapy is the mainstay of OSA treatment. The following are pregnancy-specific issues that need to be considered when managing pregnant females with PAP for OSA.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Indications </strong>– Indications for PAP therapy are the same as for nonpregnant patients (ie, patients with moderate to severe OSA and patients with mild OSA who have select indications listed in the algorithm  (<a class="graphic graphic_algorithm graphicRef70443" href="/d/graphic/70443.html" rel="external">algorithm 1</a>)). However, for pregnant patients with <strong>mild</strong> OSA, in addition to all the usual indications for PAP therapy (eg, physiologic sequalae of OSA), we also use PAP therapy if the patient has recurrent oxyhemoglobin desaturations to &lt;90 percent. The rationale is the potential for adverse effects of hypoxemia on the fetus. For patients with mild OSA who develop adverse outcomes associated with OSA (eg, hypertensive diseases of pregnancy including preeclampsia; gestational diabetes), a trial of CPAP therapy is also appropriate [<a href="#rid43">43</a>]. Indications in nonpregnant patients are discussed separately. (See  <a class="medical medical_review" href="/d/html/7695.html" rel="external">"Obstructive sleep apnea: Overview of management in adults", section on 'Indications'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Modality selection</strong> – For patients with OSA who are pregnant and who need PAP therapy, we prefer to use APAP rather than fixed-level continuous PAP (CPAP). The rationale for this approach is that for some patients, OSA control may worsen over the course of pregnancy (eg, due to upper airway changes during pregnancy or weight gain) resulting in a higher pressure requirement [<a href="#rid44">44</a>]. Thus, the use of APAP avoids the need for a formal retitration study. When prescribing APAP, we use the results of the original PAP titration study (if performed) as a guide to the range of pressures to be prescribed. </p><p></p><p class="bulletIndent1">Data to support this approach are limited. In one prospective study including 12 pregnant patients with sleep-disordered breathing (SDB), an increase in CPAP pressure of 1 to 2 cm H<sub>2</sub>O was required in half of the patients over the course of pregnancy [<a href="#rid44">44</a>].</p><p></p><p class="bulletIndent1">Mode selection and titration modules for PAP therapy are described separately. (See  <a class="medical medical_review" href="/d/html/99556.html" rel="external">"Mode selection for titration of positive airway pressure in adults with obstructive sleep apnea"</a> and  <a class="medical medical_review" href="/d/html/7677.html" rel="external">"Titration of positive airway pressure therapy for adults with obstructive sleep apnea", section on 'Auto-titrating continuous positive airway pressure (APAP)'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Efficacy and safety </strong>– Data describing the efficacy of PAP in pregnant females are limited [<a href="#rid43">43-45</a>]. In general, PAP improves sleepiness, snoring, and fatigue, similar to that seen in the nonpregnant population. </p><p></p><p class="bulletIndent1">However, the impact on other clinically relevant outcomes such as blood pressure control is unclear. In one prospective study including 11 pregnant patients with OSA and severe preeclampsia, APAP resulted in a reduction in mean nocturnal blood pressure [<a href="#rid45">45</a>], although, study limitations warrant cautious interpretation of this study. </p><p></p><p class="bulletIndent1">Trials examining the effect of PAP therapy on outcomes including blood pressure and cardiovascular risk are in progress [<a href="#rid46">46,47</a>].<strong> </strong></p><p></p><p class="bulletIndent1">In our experience adverse effects are similar to those in the general population. Limited data suggest that the theoretical concern for decreased cardiac output due to the applied positive intrathoracic pressure from PAP therapy is not clinically important. In a randomized trial including 24 patients with severe preeclampsia, cardiac output but remained at baseline when the patients were treated with APAP but decreased during sleep (from 7.7 L/min to 5.7 L/min) in those who were not treated with APAP [<a href="#rid48">48</a>]. However, these data may not apply to pregnant patients with OSA who do not have preeclampsia. (See  <a class="medical medical_review" href="/d/html/7702.html" rel="external">"Assessing and managing nonadherence with continuous positive airway pressure (CPAP) for adults with obstructive sleep apnea", section on 'Side effect management'</a>.)</p><p></p><p><strong>Follow-up</strong> <strong>and adherence</strong> – Regardless of the selected modality, we follow-up patients within one to two weeks after initiation of PAP therapy and regularly thereafter (eg, every one to three months during pregnancy) so that adherence to and efficacy of PAP treatment can be assessed and adjusted as needed. </p><p class="bulletIndent1">It is estimated that only 50 percent of all patients are adherent to PAP therapy. While rates of nonadherence have not been formally studied in pregnant patients, our experience suggest that it may be similar to the general population. Pregnant patients in our clinics often cite nasal congestion and lack of symptomatic improvement as reasons for nonadherence. The approach to nonadherence is discussed separately. (See  <a class="medical medical_review" href="/d/html/7695.html" rel="external">"Obstructive sleep apnea: Overview of management in adults", section on 'Follow-up'</a> and  <a class="medical medical_review" href="/d/html/7702.html" rel="external">"Assessing and managing nonadherence with continuous positive airway pressure (CPAP) for adults with obstructive sleep apnea"</a>.)</p><p></p><p class="headingAnchor" id="H136232081"><span class="h3">Treatments of limited benefit</span></p><p class="headingAnchor" id="H2093428730"><span class="h4">Mandibular advancement devices</span><span class="headingEndMark"> — </span>Customized oral mandibular advancement devices are noninvasive devices that keep the airway open by pulling the lower jaw forward. They can be used when PAP fails or is poorly tolerated or as first-line therapy in selected patients [<a href="#rid49">49,50</a>]. </p><p>While they can be effective at improving OSA control in nonpregnant patients, only 35 to 40 percent of patients achieve a reduction in the degree of OSA to normal levels (ie, AHI &lt;5 events/hour), and oxyhemoglobin saturation levels often do not return to normal [<a href="#rid51">51</a>]. The potential for fetal hypoxemia, the multiple fittings that can be needed to initiate oral appliance use, the time it takes to fabricate the device, and the potential need for frequent refitting due to gestational weight gain, make this treatment impractical for pregnant patients as initial therapy for OSA. However, when patients who are being treated successfully with an oral mandibular advancement device become pregnant, it is reasonable to continue using the device as long as OSA symptoms remain well-controlled. Recurrence of symptoms (eg, snoring, witnessed apneas) while using an oral device may indicate that the oral appliance needs to be further advanced or that switching to PAP therapy is needed. (See <a class="local">'Positive airway pressure'</a> above.)</p><p>No mandibular advancement device data exist in pregnant patients with OSA, but clinical trials are in progress. Data that support oral devices in the general population are described separately. (See  <a class="medical medical_review" href="/d/html/7678.html" rel="external">"Oral appliances in the treatment of obstructive sleep apnea in adults"</a>.)</p><p class="headingAnchor" id="H205070311"><span class="h4">Surgery</span><span class="headingEndMark"> — </span>Surgical treatments for mild to moderate OSA, such as uvulopalatopharyngoplasty, generally achieve a reduction in AHI to the normal range in less than half of nonpregnant patients with OSA [<a href="#rid52">52</a>]. However, in pregnant patients, given the relative lack of efficacy and the potential for adverse consequences associated with surgery and anesthesia (which are likely to be magnified during pregnancy), surgeries for OSA are generally not suitable approaches. The surgical treatment of OSA is discussed separately. (See  <a class="medical medical_review" href="/d/html/97861.html" rel="external">"Surgical treatment of obstructive sleep apnea in adults"</a>.)</p><p class="headingAnchor" id="H3451194580"><span class="h3">Treatments not used: Pharmacologic therapy</span><span class="headingEndMark"> — </span>Wakefulness promoting agents (eg, <a class="drug drug_general" data-topicid="10157" href="/d/drug information/10157.html" rel="external">modafinil</a>) are sometimes used in <strong>non</strong>pregnant patients with adequately-treated OSA who have persistent, burdensome daytime sleepiness and in whom alternative causes of daytime sleepiness have been excluded. </p><p>However, in pregnant patients, we advise <strong>against</strong> the use of wakefulness-promoting agents and we discontinue these agents if patients are already taking them prior to becoming pregnant. The rationale for this approach is that two wakefulness promoting agents (<a class="drug drug_general" data-topicid="10157" href="/d/drug information/10157.html" rel="external">modafinil</a> and <a class="drug drug_general" data-topicid="9260" href="/d/drug information/9260.html" rel="external">armodafinil</a>), have been shown to be associated with an increased risk of major congenital anomalies [<a href="#rid53">53-55</a>]. We also extend this recommendation to lactating individuals since limited data suggest that modafinil may be present in breast milk and the effects in infants are unknown [<a href="#rid56">56</a>]. The pregnancy and lactation risks of <a class="drug drug_general" data-topicid="120816" href="/d/drug information/120816.html" rel="external">solriamfetol</a> are unknown [<a href="#rid57">57</a>]. </p><p>When these agents are discontinued, patients should be warned about increased sleepiness and should take appropriate precautions, such as when driving.</p><p>Use of these agents in nonpregnant patients with OSA and pregnant patients with narcolepsy are discussed separately. (See  <a class="medical medical_review" href="/d/html/7687.html" rel="external">"Evaluation and management of residual excessive sleepiness in adults with obstructive sleep apnea"</a> and  <a class="medical medical_review" href="/d/html/7681.html" rel="external">"Treatment of narcolepsy in adults", section on 'Pregnancy and lactation'</a>.) </p><p class="headingAnchor" id="H4053406725"><span class="h2">Management of OSA-related pregnancy issues</span><span class="headingEndMark"> — </span>As OSA is associated with increased maternal and fetal morbidity (see <a class="local">'Maternal outcomes'</a> below and <a class="local">'Fetal outcomes'</a> below), we perform the following in pregnant patients with OSA: </p><p class="bulletIndent1"><span class="glyph">●</span>Monitor blood pressure and urine protein during routine prenatal care visits. (See  <a class="medical medical_review" href="/d/html/83303.html" rel="external">"Prenatal care: Second and third trimesters", section on 'Routine ongoing assessments'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>First- or early second-trimester testing for gestational diabetes with a glucose-tolerance test to detect asymptomatic diabetes. For those with an initially negative screen, we also perform repeat screening at 24 to 28 weeks gestation. (See  <a class="medical medical_review" href="/d/html/6797.html" rel="external">"Gestational diabetes mellitus: Screening, diagnosis, and prevention", section on 'Screening for overt diabetes in early pregnancy'</a>.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Ultrasonography to estimate fetal weight every three to four weeks starting at 28 weeks gestation to detect fetal growth abnormalities. This management is similar to patients with chronic hypertension in pregnancy. (See  <a class="medical medical_review" href="/d/html/116432.html" rel="external">"Chronic hypertension in pregnancy: Prenatal and postpartum care", section on 'Screening for fetal growth restriction'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Fetal surveillance (ie, nonstress test and amniotic fluid index, biophysical profile) as indicated for OSA-associated comorbid conditions. There are no data to support fetal surveillance solely for isolated sleep apnea.</p><p></p><p class="headingAnchor" id="H748774883"><span class="h1">INTRAPARTUM MANAGEMENT</span><span class="headingEndMark"> — </span>Our approach to intrapartum management of patients with OSA is as follows:</p><p class="bulletIndent1"><span class="glyph">●</span>We instruct patients who have been using positive airway pressure (PAP) devices or an oral appliance for OSA, to bring their devices when they present to the Labor and Delivery unit. The device is not needed while awake but is encouraged during sleep. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>If not already consulted prenatally, we consult anesthesia early in the patient's labor. Early placement of regional anesthesia may prevent the need for general anesthesia if emergency cesarean birth becomes necessary. Regional anesthesia in this population may also avoid general anesthesia-associated maternal morbidity and mortality [<a href="#rid58">58</a>] and avoid the potential need for opioids to manage labor pain. (See <a class="local">'Postpartum management'</a> below and  <a class="medical medical_review" href="/d/html/13516.html" rel="external">"Surgical risk and the preoperative evaluation and management of adults with obstructive sleep apnea"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>We continuously monitor oxygenation during labor with a pulse oximeter. If desaturation is observed (eg, &lt;90 percent), we perform a comprehensive clinical evaluation to determine the etiology. This evaluation should focus on respiratory causes of hypoxemia and any potentially life-threatening causes (eg, pulmonary embolus, amniotic pulmonary embolism, aspiration, pneumothorax, cardiogenic pulmonary edema, cardiac arrythmia). (See  <a class="medical medical_review" href="/d/html/134329.html" rel="external">"Evaluation and management of the nonventilated, hospitalized adult patient with acute hypoxemia"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>For patients who undergo cesarean birth, intrapartum management of OSA is similar to that in nonpregnant patients, the details of which are discussed separately. (See  <a class="medical medical_review" href="/d/html/13517.html" rel="external">"Intraoperative management of adults with obstructive sleep apnea"</a>.)</p><p></p><p class="headingAnchor" id="H831950392"><span class="h1">POSTPARTUM MANAGEMENT</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Identification of those at risk</strong> – Scoring systems that assess the risk of perioperative complications in patients at risk for OSA may be helpful in identifying nonpregnant patients at increased risk for postdelivery complications but their use may be limited in pregnant patients [<a href="#rid28">28</a>]. These are described separately. (See  <a class="medical medical_review" href="/d/html/13518.html" rel="external">"Postoperative management of adults with obstructive sleep apnea", section on 'Postoperative complications'</a> and  <a class="medical medical_review" href="/d/html/13516.html" rel="external">"Surgical risk and the preoperative evaluation and management of adults with obstructive sleep apnea", section on 'Perioperative complications'</a> and  <a class="medical medical_review" href="/d/html/13516.html" rel="external">"Surgical risk and the preoperative evaluation and management of adults with obstructive sleep apnea", section on 'Initial assessment'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Management</strong> – Following delivery (vaginal or cesarean birth), we apply the same principles of management as nonpregnant patients with OSA in the postoperative setting. This involves management in the upright position, pain control with the avoidance of opioids, and resumption of airway management as soon as is feasible with whatever device was in place prior to delivery (eg, positive airway pressure [PAP], oral device). Consulting with a sleep medicine specialist, if not already done, is also appropriate. In addition, patients with OSA should be counseled about the risks of excessive sleepiness for the safe provision of breast feeding and childcare. Further details on the postoperative management of patients with OSA are provided separately. (See  <a class="medical medical_review" href="/d/html/13518.html" rel="external">"Postoperative management of adults with obstructive sleep apnea", section on 'General strategies'</a> and  <a class="medical medical_review" href="/d/html/13518.html" rel="external">"Postoperative management of adults with obstructive sleep apnea", section on 'Positive airway pressure therapy'</a> and  <a class="medical medical_review" href="/d/html/4978.html" rel="external">"Breastfeeding: Parental education and support", section on 'Maternal exhaustion'</a>.)</p><p></p><p class="bulletIndent1">Limited data in pregnant patients support this approach. In a study of 20 postpartum patients with moderate to severe OSA (ie, apnea-hypopnea index [AHI] &gt;15/h), elevated upper body positioning reduced the AHI from 7.7±2.2/h to 4.5±1.4/h [<a href="#rid59">59</a>]. (See  <a class="medical medical_review" href="/d/html/13518.html" rel="external">"Postoperative management of adults with obstructive sleep apnea"</a>.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Follow-up</strong> – All pregnant patients diagnosed with OSA should be followed postpartum by a sleep medicine specialist for reassessment of OSA severity (eg, re-evaluation of PAP prescription requirements, oral appliance prescription, weight management). </p><p></p><p class="bulletIndent1">For patients diagnosed with gestational OSA, we typically repeat testing (home sleep apnea testing or full-night, attended, in-laboratory polysomnography [PSG]) [<a href="#rid24">24</a>], particularly after losing their pregnancy weight. At our institutions, we generally recommend that this evaluation take place 8 to 12 weeks after delivery. However, it is important to keep in mind weight loss may occur at a slower rate, and thus, postpartum management of OSA needs to be individualized. Specific weight loss strategies may need to be applied which, in addition to improving OSA, may improve their overall health. (See  <a class="medical medical_review" href="/d/html/7695.html" rel="external">"Obstructive sleep apnea: Overview of management in adults", section on 'Weight loss and exercise'</a>.) </p><p></p><p class="bulletIndent1">For patients with prepregnancy OSA whose disease severity worsened or improved during pregnancy, the need for repeat testing or switching to APAP is individualized. </p><p></p><p class="bulletIndent1">Data that describe the course of OSA following delivery are limited. In one longitudinal study including 10 patients who presented with a sleep-related breathing disorder in the third trimester, sleep apnea severity improved after delivery [<a href="#rid60">60</a>]. However, the majority (70 percent) of patients continued to have the disorder up to three months postpartum. This study did not account for possible body position effects on the degree of sleep-disordered breathing (SDB), postpartum weight loss, and changes in body fat composition and distribution, all of which possibly contributed to these findings.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Future pregnancies</strong> – There are no data regarding the effect of a subsequent pregnancy on the natural history of OSA or whether the development of OSA during one pregnancy increases the risk of developing OSA in subsequent pregnancies. Similarly, whether a prior history of gestational OSA affects risk for adverse maternal-fetal outcomes in subsequent pregnancies (regardless of whether OSA has recurred) has not been reported. In our experience, patients with OSA and body mass index (BMI) ≥40 kg/m<sup>2</sup> have experienced a regression of OSA with substantial weight loss; in the absence of such changes, subsequent pregnancies are also affected by OSA.</p><p></p><p class="bulletIndent1">OSA may be associated with increased rates of infertility. In a retrospective study, higher rates of OSA were reported in females with infertility compared with matched controls who did not have infertility (1.4 versus 0.6 percent; adjusted odds ratio [OR] 2.1) [<a href="#rid61">61</a>]. While the cause infertility is patients with OSA is uncertain, such patients have an increased prevalence of polycystic ovary syndrome, which is a known cause of infertility [<a href="#rid62">62</a>]. </p><p></p><p class="headingAnchor" id="H3371252344"><span class="h1">OUTCOMES</span><span class="headingEndMark"> — </span>While OSA appears to be associated with an increased risk of adverse outcomes in pregnancy [<a href="#rid2">2,22,63-78</a>], data have been hindered by the inclusion of patients with a variety of sleep disorders, lack of adjustment for potential confounders, low numbers, and publication bias. Whether OSA treatment ameliorates these adverse outcomes is unknown.</p><p class="headingAnchor" id="H1720858281"><span class="h2">Maternal outcomes</span></p><p class="headingAnchor" id="H514274275"><span class="h3">Severe maternal morbidity</span><span class="headingEndMark"> — </span>OSA is associated with severe maternal morbidity (SMM). In a study based on maternal discharge codes that included more than 55 million patients, OSA was associated with an increased odds of the following indicators of SMM: eclampsia (odds ratio [OR] 5.4, 95% CI 3.3-8.9), cardiomyopathy (OR 9, 95% CI 7.5-10.9), and pulmonary embolism (OR 4.5, 95% CI 2.3-8.9); in-hospital mortality was also increased (OR 5.3, 95% CI 2.4-11.5) [<a href="#rid63">63</a>]. The findings were confirmed in another, smaller sample of 1.5 million pregnant patients with a discharge diagnosis of OSA [<a href="#rid64">64</a>]. </p><p class="headingAnchor" id="H1586952361"><span class="h3">Hypertensive disorders of pregnancy</span><span class="headingEndMark"> — </span>OSA is associated with the development of both preeclampsia and gestational hypertension [<a href="#rid2">2,63,65</a>]. In a meta-analysis of pregnant patients from 120 observational studies, compared with patients without sleep disturbances, those with objectively diagnosed OSA had an increased risk for preeclampsia (OR 2.36, 95% CI 2-2.79) and gestational hypertension (OR 1.93, 95% CI 1.51-2.46) [<a href="#rid66">66</a>]. This is consistent with data from nonpregnant patients with OSA who also are at increased risk of developing hypertension. (See  <a class="medical medical_review" href="/d/html/7706.html" rel="external">"Clinical presentation and diagnosis of obstructive sleep apnea in adults", section on 'Complications'</a>.)</p><p class="headingAnchor" id="H2817139775"><span class="h3">Gestational diabetes</span><span class="headingEndMark"> — </span>OSA is associated with the development of gestational diabetes (GDM) [<a href="#rid2">2,67-69</a>]. In a meta-analysis of observational studies, pregnant patients with OSA had an approximately two-fold increased risk of GDM compared with patients without sleep disturbances (OR 1.88, 95% CI 1.47-2.4) [<a href="#rid66">66</a>].</p><p>The severity of OSA may be directly associated with higher glucose levels. In one cross-sectional study of 65 pregnant patients with GDM between 24 and 34 weeks of gestation, patients with an apnea-hypopnea index (AHI) ≥30 events/hour of sleep had higher glucose levels during nocturnal and early morning periods compared with those who had an AHI &lt;10 events/hour, even after adjustment for body mass index (BMI) and use of insulin/<a class="drug drug_general" data-topicid="9621" href="/d/drug information/9621.html" rel="external">metformin</a> [<a href="#rid70">70</a>]. Specifically, for every 10-unit increase in AHI, nocturnal and morning glucose levels rose by 3.6 mg/dL (0.2 mmol/L; 95% CI 0.04-0.4) and 4.7 mg/dL (0.26 mmol/L; 95% CI 0.08-0.4), respectively.</p><p class="headingAnchor" id="H457312391"><span class="h3">Metabolic syndrome</span><span class="headingEndMark"> — </span>OSA may be associated with metabolic syndrome. In one study of pregnant patients with sleep-disordered breathing (SDB), those with an AHI ≥5 had an increased risk of metabolic syndrome compared with those who had an AHI &lt;5 events per hour (adjusted risk ratio [aRR] 1.4, 95% CI 1.1-1.9) [<a href="#rid79">79</a>]. This risk was even higher in those in whom OSA persisted after delivery (aRR 2.5, 95% CI 1.6-3.8). </p><p class="headingAnchor" id="H1127047942"><span class="h2">Fetal outcomes</span></p><p class="headingAnchor" id="H4261768288"><span class="h3">Preterm birth</span><span class="headingEndMark"> — </span>Population-based studies have described an increased frequency of preterm birth in patients with sleep apnea [<a href="#rid22">22,80-83</a>]. In a meta-analysis of observational studies, those with objectively diagnosed OSA had an increased risk for preterm birth compared with patients without sleep disturbances (OR 1.38, 95% CI 1.26-1.51) [<a href="#rid66">66</a>]. However, data are limited by inclusion of studies with different forms of sleep-related breathing disorders, lack of rigorous diagnostic criteria, and lack of adjustment for potential maternal confounders, particularly maternal age and BMI. </p><p class="headingAnchor" id="H3261089996"><span class="h3">Fetal heart rate deceleration</span><span class="headingEndMark"> — </span>The impact of maternal OSA on fetal heart rate patterns is unclear since studies have reported contrasting findings:</p><p class="bulletIndent1"><span class="glyph">●</span>In a cohort study in which 100 pregnant patients underwent simultaneous fetal monitoring and in hospital polysomnography (PSG), apneic episodes were not associated with abnormality of the fetal heart rate tracing [<a href="#rid84">84</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In a cohort study of 40 pregnant patients in the third trimester, the majority (84 percent) of late and/or prolonged fetal heart rate decelerations occurred within 30 seconds after a respiratory event [<a href="#rid76">76</a>]. However, there was a high rate of hypertensive disease, diabetes, and obesity (mean BMI 36 to 37 kg/m<sup>2</sup>) in this cohort, creating uncertainty about the confounding effects of these comorbidities. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In a prospective study of 84 pregnant patients (mean gestational age 36 weeks) with BMI ≥30 kg/m<sup>2 </sup>undergoing simultaneous fetal monitoring and laboratory-based PSG, only a minority (1.5 percent) of apnea or hypopnea events were followed by decelerations [<a href="#rid85">85</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>At least two other case reports have described an association between OSA and fetal heart decelerations [<a href="#rid71">71,72</a>]. </p><p></p><p class="headingAnchor" id="H192048795"><span class="h3">Low birth weight</span><span class="headingEndMark"> — </span>Although case reports and retrospective studies have described an association between OSA and impaired fetal growth, confounders that affect birth weight negatively (eg, preeclampsia, poor gestational weight gain) and positively (eg, obesity, diabetes, excessive gestational weight gain) were not adjusted for in analyses [<a href="#rid73">73-75,77,80</a>]. In a systematic review evaluating the effects of SDB in pregnancy, those with SDB had a modest increase in low birth weight neonates compared with those without SDB (&lt;2500 g, OR 1.67, 95% CI 1.00-2.78) [<a href="#rid22">22</a>]. By contrast, in subsequent meta-analyses including only studies with objectively assessed SDB, patients with and without SDB had similar rates of small-for-gestational-age [<a href="#rid66">66,86</a>] and large-for-gestational-age neonates [<a href="#rid66">66</a>]. </p><p class="headingAnchor" id="H287642711"><span class="h3">Congenital anomalies</span><span class="headingEndMark"> — </span>Limited data suggest that OSA may be associated with congenital anomalies. In a population-based study in which over 1,400,000 maternal records were linked to live newborn records, OSA was associated with an increased risk for congenital anomalies (adjusted OR 1.26, 1.11-1.43) [<a href="#rid87">87</a>]. Newborns of mothers with OSA were also more likely to be admitted to the intensive care unit (25.3 versus 8.1 percent). </p><p class="headingAnchor" id="H3124097874"><span class="h3">Fetal death</span><span class="headingEndMark"> — </span>There are no high-quality data evaluating how maternal OSA affects the risk of fetal demise. One meta-analysis reported an increased risk of stillbirth in pregnant patients with OSA (OR 1.25, 95% CI 1.08-1.45) [<a href="#rid66">66</a>]. </p><p class="headingAnchor" id="H2937775547"><span class="h1">SPECIAL CONSIDERATIONS</span></p><p class="headingAnchor" id="H2932151448"><span class="h2">Snoring</span><span class="headingEndMark"> — </span>In nonpregnant patients, snoring may be associated with increased upper airway resistance, and/or obstructive apneas and hypopneas. Data in pregnant patients are limited:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Prevalence</strong> – The prevalence of snoring in pregnant patients has been estimated to be between 14 and 53 percent and may be higher than that reported in nonpregnant females [<a href="#rid8">8,88-91</a>]. The prevalence of frequent snoring (≥3 nights/week) increases as gestation advances [<a href="#rid8">8,91</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Effect of snoring on outcomes</strong> – Observational data are conflicting regarding the effect of snoring on pregnancy and neonatal outcomes [<a href="#rid88">88-90,92-96</a>]. However, patients with a diagnosis of sleep-disordered breathing (SDB) were not excluded from these studies, thereby limiting interpretation of these outcomes. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Maternal outcomes</strong> – Higher rates of gestational hypertension [<a href="#rid90">90</a>] and preeclampsia [<a href="#rid88">88,92</a>], have been reported among habitual snorers compared with nonsnorers during pregnancy. However, studies comparing new-onset snoring in pregnancy with chronic snoring as a risk factor for preeclampsia and gestational hypertension have conflicting results [<a href="#rid90">90,93</a>]. </p><p></p><p class="bulletIndent2">Snoring may also increase the risk of gestational diabetes. In a prospective cohort study including over 15,700 females, those who reported habitual snoring were more likely than nonsnorers to develop gestational diabetes (odds ratio [OR] 2.50, 95% CI 1.34-4.67) [<a href="#rid95">95</a>]. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Neonatal outcomes</strong> – Similarly, while some studies have shown higher rates of small-for-gestational age infants in habitual snorers compared with nonsnorers [<a href="#rid88">88,94</a>], other studies have failed to find significant differences between infants born to snorers and nonsnorers [<a href="#rid89">89,96</a>].</p><p></p><p class="headingAnchor" id="H1895689119"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/113310.html" rel="external">"Society guideline links: Sleep-related breathing disorders in adults"</a>.)</p><p class="headingAnchor" id="H13387321"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Scope</strong> – Obstructive sleep apnea (OSA) refers to apneas and hypopneas (absent or severely reduced airflow, respectively) that occur during sleep despite respiratory effort. (See <a class="local">'Introduction'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Rates of OSA in pregnant patients may be higher than that reported in the nonpregnant population. Hormonal and physiologic changes that occur in pregnancy may contribute to the development and worsening severity of OSA in such patients. (See <a class="local">'Prevalence'</a> above and <a class="local">'Pathogenesis'</a> above.) </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Clinical manifestations of OSA are similar in pregnant and nonpregnant patients  (<a class="graphic graphic_table graphicRef55633" href="/d/graphic/55633.html" rel="external">table 1</a>). The clinician should have a lower than usual threshold to suspect OSA in pregnancy since the symptoms of OSA and pregnancy overlap. (See <a class="local">'Clinical manifestations'</a> above and  <a class="medical medical_review" href="/d/html/7706.html" rel="external">"Clinical presentation and diagnosis of obstructive sleep apnea in adults"</a>.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diagnostic evaluation</strong> – Our approach is the following (see <a class="local">'Diagnostic evaluation'</a> above):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>For most pregnant patients with suspected OSA, we perform full-night, attended, in-laboratory polysomnography (PSG) since PSG is the diagnostic gold standard for OSA. Unattended home sleep apnea testing (HSAT) may be a reasonable alternative for patients in whom PSG is not initially approved due to insurance restrictions or declined by the patient, although a negative HSAT may not confidently exclude OSA, especially when the suspicion remains for the diagnosis. (See <a class="local">'Diagnostic evaluation'</a> above and <a class="local">'Objective testing (home or in-laboratory)'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>The diagnostic criteria for OSA in pregnant patients are similar to those in nonpregnant patients and are discussed separately. (See <a class="local">'Diagnosis and classification of severity'</a> above and  <a class="medical medical_review" href="/d/html/7706.html" rel="external">"Clinical presentation and diagnosis of obstructive sleep apnea in adults", section on 'Diagnosis'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Management</strong> – Pregnant patients with OSA should be managed by a sleep medicine specialist. Most patients are managed in a similar fashion to those who are not pregnant with the following <strong>exceptions</strong> (see <a class="local">'Management of OSA'</a> above and  <a class="medical medical_review" href="/d/html/7695.html" rel="external">"Obstructive sleep apnea: Overview of management in adults"</a>):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>While weight loss has been demonstrated to decrease the number of apnea/hypopnea episodes in nonpregnant patients, we do <strong>not </strong>typically advise weight loss in pregnancy. Rather, we encourage patients to achieve gestational weight gain at the lower limit of the recommended range which may benefit an individual's risk for pregnancy related morbidity from worsening OSA control. Further details are provided separately. (See <a class="local">'Behavior modification'</a> above and  <a class="medical medical_review" href="/d/html/441.html" rel="external">"Gestational weight gain"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>For pregnant patients with OSA, positive airway pressure (PAP) therapy is the mainstay of treatment and is similar to that in nonpregnant patients  (<a class="graphic graphic_algorithm graphicRef70443" href="/d/graphic/70443.html" rel="external">algorithm 1</a>). (See <a class="local">'Positive airway pressure'</a> above and  <a class="medical medical_review" href="/d/html/7695.html" rel="external">"Obstructive sleep apnea: Overview of management in adults", section on 'Positive airway pressure (PAP) therapy'</a>.)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>For patients with<strong> mild</strong> OSA, we suggest PAP therapy for those with recurrent oxyhemoglobin desaturations &lt;90 percent (<a class="grade" href="https://medilib.ir/uptodate/show/grade_6" rel="external">Grade 2C</a>). </p><p></p><p class="bulletIndent3"><span class="glyph">-</span>We suggest auto-adjusting continuous PAP (APAP) rather than fixed-level continuous PAP (CPAP) (<a class="grade" href="https://medilib.ir/uptodate/show/grade_6" rel="external">Grade 2C</a>). APAP avoids the need for a repeat titration study since OSA control may worsen over the course of pregnancy necessitating an increase in PAP. PAP improves sleepiness, snoring, and fatigue in pregnant patients but the impact on other clinically relevant outcomes (eg, blood pressure control) is unclear. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Mandibular devices and surgery are not pragmatic approaches to treating gestational OSA. For pregnant patients with OSA, use of wakefulness promoting agents (eg, <a class="drug drug_general" data-topicid="10157" href="/d/drug information/10157.html" rel="external">modafinil</a> and <a class="drug drug_general" data-topicid="9260" href="/d/drug information/9260.html" rel="external">armodafinil</a>) are contraindicated due to the risk of fetal harm. (See <a class="local">'Treatments of limited benefit'</a> above and <a class="local">'Treatments not used: Pharmacologic therapy'</a> above.)</p><p></p><p class="bulletIndent1">Trimester-specific management issues include the following: </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Antepartum</strong> – Antepartum surveillance with monitoring of blood pressure and urine protein during routine prenatal care visits, first- or early second-trimester testing for gestational diabetes, ultrasonography to estimate fetal weight every three to four weeks starting at 28 weeks gestation, and standard fetal surveillance as indicated for comorbid conditions. (See <a class="local">'Management of OSA-related pregnancy issues'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Intrapartum</strong> – Patients are encouraged to use their PAP or oral device for use during sleep when in the Labor and Delivery unit. We consult anesthesia early (for placement of regional anesthesia), continuously monitor oxygenation with pulse oximetry, and clinically evaluate for desaturation events. For patients who undergo cesarean birth, intrapartum management of OSA is similar to that in nonpregnant patients, the details of which are discussed separately. (See <a class="local">'Intrapartum management'</a> above and  <a class="medical medical_review" href="/d/html/13517.html" rel="external">"Intraoperative management of adults with obstructive sleep apnea"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Postpartum</strong> – Postpartum management includes ensuring the upright position, pain control with the avoidance of opioids, prompt resumption of airway management (eg, PAP, oral device), and follow-up with a sleep medicine specialist to reassess OSA severity and need for PAP as pregnancy weight is lost. Further details in nonpregnant patients are provided separately. (See <a class="local">'Postpartum management'</a> above and  <a class="medical medical_review" href="/d/html/13518.html" rel="external">"Postoperative management of adults with obstructive sleep apnea"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Outcomes</strong> – OSA is associated with increased maternal and fetal morbidity. Adverse maternal outcomes include severe maternal morbidity, gestational hypertension, preeclampsia, and gestational diabetes. Adverse fetal outcomes are less clear but may include preterm birth, fetal heart rate decelerations, congenital anomalies, and fetal death. Whether OSA treatment ameliorates these adverse outcomes is unknown. (See <a class="local">'Outcomes'</a> above.) </p><p></p><p class="headingAnchor" id="H287214069"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The UpToDate editorial staff acknowledges Robert C Basner, MD, who contributed to earlier versions of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Pien GW, Pack AI, Jackson N, et al. Risk factors for sleep-disordered breathing in pregnancy. Thorax 2014; 69:371.</a></li><li><a class="nounderline abstract_t">Facco FL, Parker CB, Reddy UM, et al. Association Between Sleep-Disordered Breathing and Hypertensive Disorders of Pregnancy and Gestational Diabetes Mellitus. Obstet Gynecol 2017; 129:31.</a></li><li><a class="nounderline abstract_t">Pien GW, Schwab RJ. Sleep disorders during pregnancy. Sleep 2004; 27:1405.</a></li><li><a class="nounderline abstract_t">Bixler EO, Vgontzas AN, Lin HM, et al. Prevalence of sleep-disordered breathing in women: effects of gender. Am J Respir Crit Care Med 2001; 163:608.</a></li><li><a class="nounderline abstract_t">Young T, Finn L, Austin D, Peterson A. Menopausal status and sleep-disordered breathing in the Wisconsin Sleep Cohort Study. Am J Respir Crit Care Med 2003; 167:1181.</a></li><li><a class="nounderline abstract_t">Young T, Palta M, Dempsey J, et al. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993; 328:1230.</a></li><li><a class="nounderline abstract_t">Dominguez JE, Grotegut CA, Wright MC, Habib AS. Obstructive Sleep Apnea Among Gravidas With Chronic Hypertension Compared to Matched Controls: A Prospective Cohort Study. Anesth Analg 2023; 136:205.</a></li><li><a class="nounderline abstract_t">Izci B, Vennelle M, Liston WA, et al. Sleep-disordered breathing and upper airway size in pregnancy and post-partum. Eur Respir J 2006; 27:321.</a></li><li><a class="nounderline abstract_t">Pilkington S, Carli F, Dakin MJ, et al. Increase in Mallampati score during pregnancy. Br J Anaesth 1995; 74:638.</a></li><li><a class="nounderline abstract_t">Shiota S, Ryan CM, Chiu KL, et al. Alterations in upper airway cross-sectional area in response to lower body positive pressure in healthy subjects. Thorax 2007; 62:868.</a></li><li><a class="nounderline abstract_t">Su MC, Chiu KL, Ruttanaumpawan P, et al. Lower body positive pressure increases upper airway collapsibility in healthy subjects. Respir Physiol Neurobiol 2008; 161:306.</a></li><li><a class="nounderline abstract_t">Redolfi S, Yumino D, Ruttanaumpawan P, et al. Relationship between overnight rostral fluid shift and Obstructive Sleep Apnea in nonobese men. Am J Respir Crit Care Med 2009; 179:241.</a></li><li><a class="nounderline abstract_t">Jafari B, Mohsenin V. Overnight rostral fluid shift in obstructive sleep apnea: does it affect the severity of sleep-disordered breathing? Chest 2011; 140:991.</a></li><li class="breakAll">Cunningham FG, Gant NF, Leveno KJ, Gilstrap LC III. Maternal Adaptations to Pregnancy. In: Williams Obstetrics, 21st ed, McGraw-Hill, New York 2001.</li><li><a class="nounderline abstract_t">Karataş M, Çam OH, Tekin M. Assessment of nasal airway patency during pregnancy and postpartum period: correlation between subjective and objective techniques. Kulak Burun Bogaz Ihtis Derg 2016; 26:92.</a></li><li><a class="nounderline abstract_t">Rees GB, Broughton Pipkin F, Symonds EM, Patrick JM. A longitudinal study of respiratory changes in normal human pregnancy with cross-sectional data on subjects with pregnancy-induced hypertension. Am J Obstet Gynecol 1990; 162:826.</a></li><li><a class="nounderline abstract_t">Zwillich CW, Natalino MR, Sutton FD, Weil JV. Effects of progesterone on chemosensitivity in normal men. J Lab Clin Med 1978; 92:262.</a></li><li><a class="nounderline abstract_t">Lee J, Eklund EE, Lambert-Messerlian G, et al. Serum Progesterone Levels in Pregnant Women with Obstructive Sleep Apnea: A Case Control Study. J Womens Health (Larchmt) 2017; 26:259.</a></li><li><a class="nounderline abstract_t">Kapsimalis F, Kryger MH. Gender and obstructive sleep apnea syndrome, part 1: Clinical features. Sleep 2002; 25:412.</a></li><li><a class="nounderline abstract_t">Bourjeily G, Raker C, Paglia MJ, et al. Patient and provider perceptions of sleep disordered breathing assessment during prenatal care: a survey-based observational study. Ther Adv Respir Dis 2012; 6:211.</a></li><li><a class="nounderline abstract_t">Edwards N, Middleton PG, Blyton DM, Sullivan CE. Sleep disordered breathing and pregnancy. Thorax 2002; 57:555.</a></li><li><a class="nounderline abstract_t">Brown NT, Turner JM, Kumar S. The intrapartum and perinatal risks of sleep-disordered breathing in pregnancy: a systematic review and metaanalysis. Am J Obstet Gynecol 2018; 219:147.</a></li><li><a class="nounderline abstract_t">Johns EC, Hill EA, Williams S, et al. High prevalence of obstructive sleep apnea in pregnant women with class III obesity: a prospective cohort study. J Clin Sleep Med 2022; 18:423.</a></li><li><a class="nounderline abstract_t">Dominguez JE, Cantrell S, Habib AS, et al. Society of Anesthesia and Sleep Medicine and the Society for Obstetric Anesthesia and Perinatology Consensus Guideline on the Screening, Diagnosis, and Treatment of Obstructive Sleep Apnea in Pregnancy. Obstet Gynecol 2023; 142:403.</a></li><li><a class="nounderline abstract_t">Louis JM, Koch MA, Reddy UM, et al. Predictors of sleep-disordered breathing in pregnancy. Am J Obstet Gynecol 2018; 218:521.e1.</a></li><li><a class="nounderline abstract_t">Izci-Balserak B, Zhu B, Gurubhagavatula I, et al. A Screening Algorithm for Obstructive Sleep Apnea in Pregnancy. Ann Am Thorac Soc 2019; 16:1286.</a></li><li><a class="nounderline abstract_t">Facco FL, Ouyang DW, Zee PC, Grobman WA. Development of a pregnancy-specific screening tool for sleep apnea. J Clin Sleep Med 2012; 8:389.</a></li><li><a class="nounderline abstract_t">Lockhart EM, Ben Abdallah A, Tuuli MG, Leighton BL. Obstructive Sleep Apnea in Pregnancy: Assessment of Current Screening Tools. Obstet Gynecol 2015; 126:93.</a></li><li><a class="nounderline abstract_t">Tantrakul V, Numthavaj P, Guilleminault C, et al. Performance of screening questionnaires for obstructive sleep apnea during pregnancy: A systematic review and meta-analysis. Sleep Med Rev 2017; 36:96.</a></li><li><a class="nounderline abstract_t">Dominguez JE, Grotegut CA, Cooter M, et al. Screening extremely obese pregnant women for obstructive sleep apnea. Am J Obstet Gynecol 2018; 219:613.e1.</a></li><li><a class="nounderline abstract_t">Pearson F, Batterham AM, Cope S. The STOP-Bang Questionnaire as a Screening Tool for Obstructive Sleep Apnea in Pregnancy. J Clin Sleep Med 2019; 15:705.</a></li><li><a class="nounderline abstract_t">Collop NA, Anderson WM, Boehlecke B, et al. Clinical guidelines for the use of unattended portable monitors in the diagnosis of obstructive sleep apnea in adult patients. Portable Monitoring Task Force of the American Academy of Sleep Medicine. J Clin Sleep Med 2007; 3:737.</a></li><li><a class="nounderline abstract_t">Kapur VK, Auckley DH, Chowdhuri S, et al. Clinical Practice Guideline for Diagnostic Testing for Adult Obstructive Sleep Apnea: An American Academy of Sleep Medicine Clinical Practice Guideline. J Clin Sleep Med 2017; 13:479.</a></li><li><a class="nounderline abstract_t">Sharkey KM, Waters K, Millman RP, et al. Validation of the Apnea Risk Evaluation System (ARES) device against laboratory polysomnography in pregnant women at risk for obstructive sleep apnea syndrome. J Clin Sleep Med 2014; 10:497.</a></li><li><a class="nounderline abstract_t">Louis J, Auckley D, Miladinovic B, et al. Perinatal outcomes associated with obstructive sleep apnea in obese pregnant women. Obstet Gynecol 2012; 120:1085.</a></li><li><a class="nounderline abstract_t">Facco FL, Parker CB, Reddy UM, et al. NuMoM2b Sleep-Disordered Breathing study: objectives and methods. Am J Obstet Gynecol 2015; 212:542.e1.</a></li><li><a class="nounderline abstract_t">Wang J, Zhang C, Xu L, et al. Home monitoring for clinically suspected obstructive sleep apnea in pregnancy. J Clin Sleep Med 2023; 19:1951.</a></li><li><a class="nounderline abstract_t">Louis J, Auckley D, Bolden N. Management of obstructive sleep apnea in pregnant women. Obstet Gynecol 2012; 119:864.</a></li><li><a class="nounderline abstract_t">Epstein LJ, Kristo D, Strollo PJ Jr, et al. Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults. J Clin Sleep Med 2009; 5:263.</a></li><li><a class="nounderline abstract_t">Holty JE, Guilleminault C. Surgical options for the treatment of obstructive sleep apnea. Med Clin North Am 2010; 94:479.</a></li><li><a class="nounderline abstract_t">Chung F, Memtsoudis SG, Ramachandran SK, et al. Society of Anesthesia and Sleep Medicine Guidelines on Preoperative Screening and Assessment of Adult Patients With Obstructive Sleep Apnea. Anesth Analg 2016; 123:452.</a></li><li><a class="nounderline abstract_t">Kent D, Stanley J, Aurora RN, et al. Referral of adults with obstructive sleep apnea for surgical consultation: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med 2021; 17:2499.</a></li><li><a class="nounderline abstract_t">Chirakalwasan N, Amnakkittikul S, Wanitcharoenkul E, et al. Continuous Positive Airway Pressure Therapy in Gestational Diabetes With Obstructive Sleep Apnea: A Randomized Controlled Trial. J Clin Sleep Med 2018; 14:327.</a></li><li><a class="nounderline abstract_t">Guilleminault C, Kreutzer M, Chang JL. Pregnancy, sleep disordered breathing and treatment with nasal continuous positive airway pressure. Sleep Med 2004; 5:43.</a></li><li><a class="nounderline abstract_t">Edwards N, Blyton DM, Kirjavainen T, et al. Nasal continuous positive airway pressure reduces sleep-induced blood pressure increments in preeclampsia. Am J Respir Crit Care Med 2000; 162:252.</a></li><li><a class="nounderline abstract_t">Pamidi S, Meltzer SJ, Garfield N, et al. A Pilot Randomized-Controlled Trial on the Effect of CPAP Treatment on Glycemic Control in Gestational Diabetes: Study Design and Methods. Front Endocrinol (Lausanne) 2018; 9:659.</a></li><li class="breakAll">Sleep Disordered Breathing, Obesity and Pregnancy Study (SOAP). Clinicaltrials.gov. Available at: https://clinicaltrials.gov/ct2/show/NCT02086448 (Accessed on March 01, 2022).</li><li><a class="nounderline abstract_t">Blyton DM, Sullivan CE, Edwards N. Reduced nocturnal cardiac output associated with preeclampsia is minimized with the use of nocturnal nasal CPAP. Sleep 2004; 27:79.</a></li><li><a class="nounderline abstract_t">Wickwire EM, Collop NA. Insomnia and sleep-related breathing disorders. Chest 2010; 137:1449.</a></li><li><a class="nounderline abstract_t">Ramar K, Dort LC, Katz SG, et al. Clinical Practice Guideline for the Treatment of Obstructive Sleep Apnea and Snoring with Oral Appliance Therapy: An Update for 2015. J Clin Sleep Med 2015; 11:773.</a></li><li><a class="nounderline abstract_t">Chan AS, Lee RW, Cistulli PA. Non-positive airway pressure modalities: mandibular advancement devices/positional therapy. Proc Am Thorac Soc 2008; 5:179.</a></li><li><a class="nounderline abstract_t">Won CH, Li KK, Guilleminault C. Surgical treatment of obstructive sleep apnea: upper airway and maxillomandibular surgery. Proc Am Thorac Soc 2008; 5:193.</a></li><li class="breakAll">Teva Pharmaceuticals Ireland. Direct Healthcare Professional Communication. Modafinil: potential risk of congenital malformations when administered during pregnancy. 7 June 2019. http://www.hpra.ie/docs/default-source/default-document-library/important-safety-information---modafinil99170c2697826eee9b55ff00008c97d0.pdf.</li><li class="breakAll">https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2019/70201a-eng.php (Accessed on July 15, 2019).</li><li><a class="nounderline abstract_t">Damkier P, Broe A. First-Trimester Pregnancy Exposure to Modafinil and Risk of Congenital Malformations. JAMA 2020; 323:374.</a></li><li><a class="nounderline abstract_t">Aurora S, Aurora N, Datta P, et al. Evaluating Transfer of Modafinil Into Human Milk During Lactation: A Case Report. J Clin Sleep Med 2018; 14:2087.</a></li><li><a class="nounderline abstract_t">Abad VC. Profile of Solriamfetol in the Management of Excessive Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea: Focus on Patient Selection and Perspectives. Nat Sci Sleep 2021; 13:75.</a></li><li><a class="nounderline abstract_t">Passannante AN, Tielborg M. Anesthetic management of patients with obesity with and without sleep apnea. Clin Chest Med 2009; 30:569.</a></li><li><a class="nounderline abstract_t">Zaremba S, Mueller N, Heisig AM, et al. Elevated upper body position improves pregnancy-related OSA without impairing sleep quality or sleep architecture early after delivery. Chest 2015; 148:936.</a></li><li><a class="nounderline abstract_t">Edwards N, Blyton DM, Hennessy A, Sullivan CE. Severity of sleep-disordered breathing improves following parturition. Sleep 2005; 28:737.</a></li><li><a class="nounderline abstract_t">Lim ZW, Wang ID, Wang P, et al. Obstructive sleep apnea increases risk of female infertility: A 14-year nationwide population-based study. PLoS One 2021; 16:e0260842.</a></li><li><a class="nounderline abstract_t">Kahal H, Kyrou I, Uthman OA, et al. The prevalence of obstructive sleep apnoea in women with polycystic ovary syndrome: a systematic review and meta-analysis. Sleep Breath 2020; 24:339.</a></li><li><a class="nounderline abstract_t">Louis JM, Mogos MF, Salemi JL, et al. Obstructive sleep apnea and severe maternal-infant morbidity/mortality in the United States, 1998-2009. Sleep 2014; 37:843.</a></li><li><a class="nounderline abstract_t">Bourjeily G, Danilack VA, Bublitz MH, et al. Obstructive sleep apnea in pregnancy is associated with adverse maternal outcomes: a national cohort. Sleep Med 2017; 38:50.</a></li><li><a class="nounderline abstract_t">Pamidi S, Pinto LM, Marc I, et al. Maternal sleep-disordered breathing and adverse pregnancy outcomes: a systematic review and metaanalysis. Am J Obstet Gynecol 2014; 210:52.e1.</a></li><li><a class="nounderline abstract_t">Lu Q, Zhang X, Wang Y, et al. Sleep disturbances during pregnancy and adverse maternal and fetal outcomes: A systematic review and meta-analysis. Sleep Med Rev 2021; 58:101436.</a></li><li><a class="nounderline abstract_t">Reutrakul S, Zaidi N, Wroblewski K, et al. Sleep disturbances and their relationship to glucose tolerance in pregnancy. Diabetes Care 2011; 34:2454.</a></li><li><a class="nounderline abstract_t">Qiu C, Enquobahrie D, Frederick IO, et al. Glucose intolerance and gestational diabetes risk in relation to sleep duration and snoring during pregnancy: a pilot study. BMC Womens Health 2010; 10:17.</a></li><li><a class="nounderline abstract_t">Bourjeily G, Raker CA, Chalhoub M, Miller MA. Pregnancy and fetal outcomes of symptoms of sleep-disordered breathing. Eur Respir J 2010; 36:849.</a></li><li><a class="nounderline abstract_t">Newbold R, Benedetti A, Kimoff RJ, et al. Maternal Sleep-Disordered Breathing in Pregnancy and Increased Nocturnal Glucose Levels in Women with Gestational Diabetes Mellitus. Chest 2021; 159:356.</a></li><li><a class="nounderline abstract_t">Roush SF, Bell L. Obstructive sleep apnea in pregnancy. J Am Board Fam Pract 2004; 17:292.</a></li><li><a class="nounderline abstract_t">Sahin FK, Koken G, Cosar E, et al. Obstructive sleep apnea in pregnancy and fetal outcome. Int J Gynaecol Obstet 2008; 100:141.</a></li><li><a class="nounderline abstract_t">Charbonneau M, Falcone T, Cosio MG, Levy RD. Obstructive sleep apnea during pregnancy. Therapy and implications for fetal health. Am Rev Respir Dis 1991; 144:461.</a></li><li><a class="nounderline abstract_t">Joel-Cohen SJ, Schoenfeld A. Fetal response to periodic sleep apnea: a new syndrome in obstetrics. Eur J Obstet Gynecol Reprod Biol 1978; 8:77.</a></li><li><a class="nounderline abstract_t">Schoenfeld A, Ovadia Y, Neri A, Freedman S. Obstructive sleep apnea (OSA)-implications in maternal-fetal medicine. A hypothesis. Med Hypotheses 1989; 30:51.</a></li><li><a class="nounderline abstract_t">Pitts DS, Treadwell MC, O'Brien LM. Fetal Heart Rate Decelerations in Women with Sleep-Disordered Breathing. Reprod Sci 2021; 28:2602.</a></li><li><a class="nounderline abstract_t">Kneitel AW, Treadwell MC, O'Brien LM. Effects of maternal obstructive sleep apnea on fetal growth: a case-control study. J Perinatol 2018; 38:982.</a></li><li><a class="nounderline abstract_t">Phan K, Pamidi S, Gomez YH, et al. Sleep-disordered breathing in high-risk pregnancies is associated with elevated arterial stiffness and increased risk for preeclampsia. Am J Obstet Gynecol 2022; 226:833.e1.</a></li><li><a class="nounderline abstract_t">Facco FL, Redline S, Hunter SM, et al. Sleep-disordered Breathing in Pregnancy and after Delivery: Associations with Cardiometabolic Health. Am J Respir Crit Care Med 2022; 205:1202.</a></li><li><a class="nounderline abstract_t">Chen YH, Kang JH, Lin CC, et al. Obstructive sleep apnea and the risk of adverse pregnancy outcomes. Am J Obstet Gynecol 2012; 206:136.e1.</a></li><li><a class="nounderline abstract_t">Louis JM, Auckley D, Sokol RJ, Mercer BM. Maternal and neonatal morbidities associated with obstructive sleep apnea complicating pregnancy. Am J Obstet Gynecol 2010; 202:261.e1.</a></li><li><a class="nounderline abstract_t">Bin YS, Cistulli PA, Ford JB. Population-Based Study of Sleep Apnea in Pregnancy and Maternal and Infant Outcomes. J Clin Sleep Med 2016; 12:871.</a></li><li><a class="nounderline abstract_t">Felder JN, Baer RJ, Rand L, et al. Sleep Disorder Diagnosis During Pregnancy and Risk of Preterm Birth. Obstet Gynecol 2017; 130:573.</a></li><li><a class="nounderline abstract_t">Olivarez SA, Maheshwari B, McCarthy M, et al. Prospective trial on obstructive sleep apnea in pregnancy and fetal heart rate monitoring. Am J Obstet Gynecol 2010; 202:552.e1.</a></li><li><a class="nounderline abstract_t">DiPietro JA, Bai J, Sgambati FP, et al. Fetal heart rate responses to maternal sleep-disordered breathing. Am J Obstet Gynecol 2023; 228:459.e1.</a></li><li><a class="nounderline abstract_t">Liu L, Su G, Wang S, Zhu B. The prevalence of obstructive sleep apnea and its association with pregnancy-related health outcomes: a systematic review and meta-analysis. Sleep Breath 2019; 23:399.</a></li><li><a class="nounderline abstract_t">Bourjeily G, Danilack VA, Bublitz MH, et al. Maternal obstructive sleep apnea and neonatal birth outcomes in a population based sample. Sleep Med 2020; 66:233.</a></li><li><a class="nounderline abstract_t">Franklin KA, Holmgren PA, Jönsson F, et al. Snoring, pregnancy-induced hypertension, and growth retardation of the fetus. Chest 2000; 117:137.</a></li><li><a class="nounderline abstract_t">Loube DI, Poceta JS, Morales MC, et al. Self-reported snoring in pregnancy. Association with fetal outcome. Chest 1996; 109:885.</a></li><li><a class="nounderline abstract_t">Dunietz GL, Hao W, Shedden K, et al. Maternal habitual snoring and blood pressure trajectories in pregnancy. J Clin Sleep Med 2022; 18:31.</a></li><li><a class="nounderline abstract_t">Facco FL, Kramer J, Ho KH, et al. Sleep disturbances in pregnancy. Obstet Gynecol 2010; 115:77.</a></li><li><a class="nounderline abstract_t">Pérez-Chada D, Videla AJ, O'Flaherty ME, et al. Snoring, witnessed sleep apnoeas and pregnancy-induced hypertension. Acta Obstet Gynecol Scand 2007; 86:788.</a></li><li><a class="nounderline abstract_t">O'Brien LM, Bullough AS, Owusu JT, et al. Pregnancy-onset habitual snoring, gestational hypertension, and preeclampsia: prospective cohort study. Am J Obstet Gynecol 2012; 207:487.e1.</a></li><li><a class="nounderline abstract_t">O'Brien LM, Bullough AS, Owusu JT, et al. Snoring during pregnancy and delivery outcomes: a cohort study. Sleep 2013; 36:1625.</a></li><li><a class="nounderline abstract_t">Qiu C, Lawrence W, Gelaye B, et al. Risk of glucose intolerance and gestational diabetes mellitus in relation to maternal habitual snoring during early pregnancy. PLoS One 2017; 12:e0184966.</a></li><li><a class="nounderline abstract_t">Stacey T, Thompson JM, Mitchell EA, et al. Association between maternal sleep practices and risk of late stillbirth: a case-control study. BMJ 2011; 342:d3403.</a></li></ol></div><div id="topicVersionRevision">Topic 14202 Version 60.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24262432" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Risk factors for sleep-disordered breathing in pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27926645" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Association Between Sleep-Disordered Breathing and Hypertensive Disorders of Pregnancy and Gestational Diabetes Mellitus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15586794" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Sleep disorders during pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11254512" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Prevalence of sleep-disordered breathing in women: effects of gender.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12615621" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Menopausal status and sleep-disordered breathing in the Wisconsin Sleep Cohort Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8464434" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : The occurrence of sleep-disordered breathing among middle-aged adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36355613" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Obstructive Sleep Apnea Among Gravidas With Chronic Hypertension Compared to Matched Controls: A Prospective Cohort Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16452587" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Sleep-disordered breathing and upper airway size in pregnancy and post-partum.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7640115" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Increase in Mallampati score during pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17442706" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Alterations in upper airway cross-sectional area in response to lower body positive pressure in healthy subjects.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18439881" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Lower body positive pressure increases upper airway collapsibility in healthy subjects.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19011149" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Relationship between overnight rostral fluid shift and Obstructive Sleep Apnea in nonobese men.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21436243" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Overnight rostral fluid shift in obstructive sleep apnea: does it affect the severity of sleep-disordered breathing?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21436243" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Overnight rostral fluid shift in obstructive sleep apnea: does it affect the severity of sleep-disordered breathing?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26890711" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Assessment of nasal airway patency during pregnancy and postpartum period: correlation between subjective and objective techniques.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2316594" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : A longitudinal study of respiratory changes in normal human pregnancy with cross-sectional data on subjects with pregnancy-induced hypertension.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/355585" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Effects of progesterone on chemosensitivity in normal men.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28103130" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Serum Progesterone Levels in Pregnant Women with Obstructive Sleep Apnea: A Case Control Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12071542" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Gender and obstructive sleep apnea syndrome, part 1: Clinical features.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22556123" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Patient and provider perceptions of sleep disordered breathing assessment during prenatal care: a survey-based observational study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12037233" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Sleep disordered breathing and pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29454869" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : The intrapartum and perinatal risks of sleep-disordered breathing in pregnancy: a systematic review and metaanalysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34351847" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : High prevalence of obstructive sleep apnea in pregnant women with class III obesity: a prospective cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37411038" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Society of Anesthesia and Sleep Medicine and the Society for Obstetric Anesthesia and Perinatology Consensus Guideline on the Screening, Diagnosis, and Treatment of Obstructive Sleep Apnea in Pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29523262" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Predictors of sleep-disordered breathing in pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31162952" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : A Screening Algorithm for Obstructive Sleep Apnea in Pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22893769" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Development of a pregnancy-specific screening tool for sleep apnea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26241261" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Obstructive Sleep Apnea in Pregnancy: Assessment of Current Screening Tools.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28007402" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Performance of screening questionnaires for obstructive sleep apnea during pregnancy: A systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30217579" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Screening extremely obese pregnant women for obstructive sleep apnea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31053210" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : The STOP-Bang Questionnaire as a Screening Tool for Obstructive Sleep Apnea in Pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18198809" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Clinical guidelines for the use of unattended portable monitors in the diagnosis of obstructive sleep apnea in adult patients. Portable Monitoring Task Force of the American Academy of Sleep Medicine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28162150" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Clinical Practice Guideline for Diagnostic Testing for Adult Obstructive Sleep Apnea: An American Academy of Sleep Medicine Clinical Practice Guideline.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24910550" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Validation of the Apnea Risk Evaluation System (ARES) device against laboratory polysomnography in pregnant women at risk for obstructive sleep apnea syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23090526" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Perinatal outcomes associated with obstructive sleep apnea in obese pregnant women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25746730" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : NuMoM2b Sleep-Disordered Breathing study: objectives and methods.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37485700" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Home monitoring for clinically suspected obstructive sleep apnea in pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22433352" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Management of obstructive sleep apnea in pregnant women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19960649" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20451028" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Surgical options for the treatment of obstructive sleep apnea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27442772" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Society of Anesthesia and Sleep Medicine Guidelines on Preoperative Screening and Assessment of Adult Patients With Obstructive Sleep Apnea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34351848" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Referral of adults with obstructive sleep apnea for surgical consultation: an American Academy of Sleep Medicine clinical practice guideline.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29458699" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Continuous Positive Airway Pressure Therapy in Gestational Diabetes With Obstructive Sleep Apnea: A Randomized Controlled Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14725826" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Pregnancy, sleep disordered breathing and treatment with nasal continuous positive airway pressure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10903250" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Nasal continuous positive airway pressure reduces sleep-induced blood pressure increments in preeclampsia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30505290" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : A Pilot Randomized-Controlled Trial on the Effect of CPAP Treatment on Glycemic Control in Gestational Diabetes: Study Design and Methods.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30505290" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : A Pilot Randomized-Controlled Trial on the Effect of CPAP Treatment on Glycemic Control in Gestational Diabetes: Study Design and Methods.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14998241" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Reduced nocturnal cardiac output associated with preeclampsia is minimized with the use of nocturnal nasal CPAP.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20525657" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Insomnia and sleep-related breathing disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26094920" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Clinical Practice Guideline for the Treatment of Obstructive Sleep Apnea and Snoring with Oral Appliance Therapy: An Update for 2015.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18250210" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Non-positive airway pressure modalities: mandibular advancement devices/positional therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18250212" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Surgical treatment of obstructive sleep apnea: upper airway and maxillomandibular surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18250212" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Surgical treatment of obstructive sleep apnea: upper airway and maxillomandibular surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18250212" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Surgical treatment of obstructive sleep apnea: upper airway and maxillomandibular surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31990303" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : First-Trimester Pregnancy Exposure to Modafinil and Risk of Congenital Malformations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30518447" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Evaluating Transfer of Modafinil Into Human Milk During Lactation: A Case Report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33531850" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Profile of Solriamfetol in the Management of Excessive Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea: Focus on Patient Selection and Perspectives.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19700053" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Anesthetic management of patients with obesity with and without sleep apnea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25905714" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Elevated upper body position improves pregnancy-related OSA without impairing sleep quality or sleep architecture early after delivery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16477961" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Severity of sleep-disordered breathing improves following parturition.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34910749" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Obstructive sleep apnea increases risk of female infertility: A 14-year nationwide population-based study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31111411" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : The prevalence of obstructive sleep apnoea in women with polycystic ovary syndrome: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24790262" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Obstructive sleep apnea and severe maternal-infant morbidity/mortality in the United States, 1998-2009.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29031756" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Obstructive sleep apnea in pregnancy is associated with adverse maternal outcomes: a national cohort.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23911687" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Maternal sleep-disordered breathing and adverse pregnancy outcomes: a systematic review and metaanalysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33571887" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Sleep disturbances during pregnancy and adverse maternal and fetal outcomes: A systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21926292" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Sleep disturbances and their relationship to glucose tolerance in pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20470416" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Glucose intolerance and gestational diabetes risk in relation to sleep duration and snoring during pregnancy: a pilot study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20525714" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Pregnancy and fetal outcomes of symptoms of sleep-disordered breathing.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32687908" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Maternal Sleep-Disordered Breathing in Pregnancy and Increased Nocturnal Glucose Levels in Women with Gestational Diabetes Mellitus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15243018" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Obstructive sleep apnea in pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17976624" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Obstructive sleep apnea in pregnancy and fetal outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1859076" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Obstructive sleep apnea during pregnancy. Therapy and implications for fetal health.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/45501" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Fetal response to periodic sleep apnea: a new syndrome in obstetrics.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2796809" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Obstructive sleep apnea (OSA)-implications in maternal-fetal medicine. A hypothesis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33847976" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Fetal Heart Rate Decelerations in Women with Sleep-Disordered Breathing.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29785058" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Effects of maternal obstructive sleep apnea on fetal growth: a case-control study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34863697" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Sleep-disordered breathing in high-risk pregnancies is associated with elevated arterial stiffness and increased risk for preeclampsia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35144521" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Sleep-disordered Breathing in Pregnancy and after Delivery: Associations with Cardiometabolic Health.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22000892" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Obstructive sleep apnea and the risk of adverse pregnancy outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20005507" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Maternal and neonatal morbidities associated with obstructive sleep apnea complicating pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27070246" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Population-Based Study of Sleep Apnea in Pregnancy and Maternal and Infant Outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28796676" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Sleep Disorder Diagnosis During Pregnancy and Risk of Preterm Birth.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20171603" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Prospective trial on obstructive sleep apnea in pregnancy and fetal heart rate monitoring.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36183777" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Fetal heart rate responses to maternal sleep-disordered breathing.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30255484" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : The prevalence of obstructive sleep apnea and its association with pregnancy-related health outcomes: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31981755" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Maternal obstructive sleep apnea and neonatal birth outcomes in a population based sample.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10631211" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Snoring, pregnancy-induced hypertension, and growth retardation of the fetus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8635365" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Self-reported snoring in pregnancy. Association with fetal outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34170225" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Maternal habitual snoring and blood pressure trajectories in pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20027038" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : Sleep disturbances in pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17611822" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : Snoring, witnessed sleep apnoeas and pregnancy-induced hypertension.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22999158" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : Pregnancy-onset habitual snoring, gestational hypertension, and preeclampsia: prospective cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24179294" id="rid93" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>94 : Snoring during pregnancy and delivery outcomes: a cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28926639" id="rid94" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>95 : Risk of glucose intolerance and gestational diabetes mellitus in relation to maternal habitual snoring during early pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21673002" id="rid95" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>96 : Association between maternal sleep practices and risk of late stillbirth: a case-control study.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
